Stocks to Sell

3 Health Care Technology Stocks to Sell Now

This week, 3 Health Care Technology stocks are worse, according to the Portfolio Graderdatabase. Each of these rates a "D" ("sell") or "F" overall ("strong sell"). Read Article

4 Insurance Stocks to Sell Now

The ratings of 4 Insurance stocks are down this week, according to the Portfolio Grader database. Each of these rates a "D" ("sell") or "F" overall ("strong sell"). Read Article

3 Machinery Stocks to Sell Now

This week, the ratings of 3 Machinery stocks on Portfolio Grader are down. Each of these rates a "D" ("sell") or "F" overall ("strong sell"). Read Article

5 Stocks With Poor Earnings Momentum — SAEX ASH EGLE BZH FCE.A

This week, these five stocks have the worst ratings in Earnings Momentum, one of the eight Fundamental Categories on Portfolio Grader. Read Article

Should You Buy Exxon Mobil Corporation (XOM) Stock? 3 Pros, 3 Cons

Exxon Mobil (XOM) is a dividend champion that's becoming more efficient. But XOM stock investors should be wary of its debt and valuation. Read Article

5 Blue-Chip Stocks to Sell for December

These five stocks to sell appear to be likely losers for December thanks to garbage charts and a weak history in a historically robust month. Read Article

Tesla Stock: The SEC Has Lifted the Veil Off TSLA

Tesla Motors (TSLA) might end up soaring or stumbling as a result of new accounting rules. But Tesla stock holders can kiss guesswork goodbye. Read Article

Two-Faced Twitter Inc (TWTR) Stock Has Only One Direction — Down.

Don't let Twitter fool you. TWTR stock looks like a discount on paper thanks to unrivaled volatility, but it's a perpetual bull trap. Read Article

Alibaba Group Holding Ltd (BABA) Stock Has Too Many Problems

Alibaba has far too many political risks behind it. For that reason, investors should steer clear of BABA stock. Read Article

This Could Send Facebook Inc (FB) Stock to the Guillotine

Facebook stock is still the king of social media investing. However, FB needs to address this problem, and soon, on its own terms. Read Article

11 Health Care Providers & Services Stocks to Sell Now

This week, the ratings of 11 Health Care Providers & Services stocks on Portfolio Grader are down. Each of these rates a "D" ("sell") or "F" overall ("strong sell"). Read Article

4 Multiline Retail Stocks to Sell Now

This week, the ratings of 4 Multiline Retail stocks on Portfolio Grader are down. Each of these rates a "D" ("sell") or "F" overall ("strong sell"). Read Article

3 Food & Staples Retailing Stocks to Sell Now

The ratings of 3 Food & Staples Retailing stocks are down this week, according to the Portfolio Grader database. Each of these rates a "D" ("sell") or "F" overall ("strong sell"). Read Article

5 Stocks With Awful Earnings Growth — EMG ITG PACB ADPT ORBC

This week, these five stocks have the worst ratings in Earnings Growth, one of the eight Fundamental Categories on Portfolio Grader. Read Article

4 Food Products Stocks to Sell Now

This week, 4 Food Products stocks are worse, according to the Portfolio Graderdatabase. Each of these rates a "D" ("sell") or "F" overall ("strong sell"). Read Article

5 Stocks With Poor Free Cash Flow — CMLS CETC CCCL I RLJE

This week, these five stocks have the worst ratings in Free Cash Flow, one of the eight Fundamental Categories on Portfolio Grader. Read Article

3 Food Stocks to Shelve Before They Turn Sour

If you think food stocks are volatile now, a Republican-dominated government won't make things any more attractive for PF, HRL and TSN. Read Article

3 Reasons to Sell Your Netflix Inc (NFLX) Stock Now

Netflix is the name to beat within the on-demand video business, but that doesn't inherently make NFLX stock a must-have investment. Read Article

Is It Time to Dump Boston Beer Company Inc? (SAM)

Boston Beer (SAM) remains susceptible to troubles plaguing its Samuel Adams brand and weak depletion trends, which is hurting its results. Read Article

24 Biotechnology Stocks to Sell Now

This week, the ratings of 24 Biotechnology stocks on Portfolio Grader are down. Each of these rates a "D" ("sell") or "F" overall ("strong sell"). Read Article